EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug and Clinical Candidate Drug Data in ChEMBL

Fiona M I Hunter iD, Harris Ioannidis iD, A Patrícia Bento, Nicolas Bosc iD, Sybilla Corbett, Eloy Felix iD, M Paula Magarinos, Emma Manners, Ines A Smit, Marleen de Veij, Noel M O'Boyle, Barbara Zdrazil iD und 1 weitere

Journal of Medicinal Chemistry · 09.10.2025 · 68 (19) · 19800-19827

DOI: 10.1021/acs.jmedchem.5c00920 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 19.09.2025. Verfasst von Fiona M I Hunter und 12 weiteren Autor:innen. Beteiligte Einrichtung: European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom. Hauptthemen laut MEDLINE: Drug Discovery, Databases, Pharmaceutical, Databases, Factual. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, European Bioinformatics Institute, Open Targets.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ChEMBL is a large-scale, open-access, FAIR database of bioactive molecules with drug-like properties. ChEMBL 35 contains 17,500 approved drugs, and drugs that are progressing through the clinical development pipeline. Drug curation has formed an integral part of the core offering of the ChEMBL database since its inception. The paper is a reference guide to present the principles of why the ChEMBL drug data has been curated in a particular manner so that data users can better understand the nature of the data. The drug data include information on: names, synonyms and trade names, chemical structure or biological sequence, data sources, indications, mechanisms, warnings and drug properties such as maximum phase of development, type of molecule, prodrug status and first approval. The integrated nature of the drug data within the context of a bioactivity resource enables the wide use of the data set in drug discovery, AI and machine learning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryDatabases, PharmaceuticalDatabases, FactualHumansPharmaceutical PreparationsMachine Learning

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.

ORCID-Profile: Fiona M I Hunter, Harris Ioannidis, Nicolas Bosc, Eloy Felix, Barbara Zdrazil

Förderung

  • Wellcome Trust
  • European Bioinformatics Institute
  • Open Targets

Zitieren

APA

Hunter, F. M. I., Ioannidis, H., Bento, A. P., Bosc, N., Corbett, S., Felix, E., Magarinos, M. P., Manners, E., Smit, I. A., de Veij, M., O'Boyle, N. M., Zdrazil, B., & Leach, A. R. (2025). Drug and Clinical Candidate Drug Data in ChEMBL. Journal of Medicinal Chemistry, 68(19), 19800-19827. https://doi.org/10.1021/acs.jmedchem.5c00920

Vancouver

Hunter FMI, Ioannidis H, Bento AP, Bosc N, Corbett S, Felix E, et al. Drug and Clinical Candidate Drug Data in ChEMBL. Journal of Medicinal Chemistry. 2025;68(19):19800-19827. doi:10.1021/acs.jmedchem.5c00920

BibTeX
@article{Hunter2025,
  author = {Hunter, Fiona M I and Ioannidis, Harris and Bento, A Patrícia and Bosc, Nicolas and Corbett, Sybilla and Felix, Eloy and Magarinos, M Paula and Manners, Emma and Smit, Ines A and de Veij, Marleen and O'Boyle, Noel M and Zdrazil, Barbara and Leach, Andrew R},
  title = {Drug and Clinical Candidate Drug Data in ChEMBL},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {19},
  pages = {19800--19827},
  doi = {10.1021/acs.jmedchem.5c00920}
}
Kostenlos starten →